Sudden Unexpected Death in Epilepsy (SUDEP) is a term used to describe the sudden and unexpected death of a person with epilepsy, where no other cause of death is found upon investigation, including autopsy. It’s a tragic occurrence that can happen to individuals with epilepsy, even if their seizures were previously well-controlled.
Since pioneering the first privately funded SUDEP research program 20 years ago, CURE Epilepsy has funded 40 grants for a total of $5.8M.
SUDEP InitiativeThe exact number of people who suffer from Sudden Unexpected Death in Epilepsy (SUDEP) is difficult to determine due to various factors, including underreporting and differences in reporting criteria across different regions and healthcare systems.
However, it is estimated that over 3,000 people will die each year from SUDEP, and it can happen to anyone with epilepsy, although certain individuals are at a greater risk.
The exact cause of Sudden Unexpected Death in Epilepsy (SUDEP) is still not fully understood, but researchers have identified several factors that may contribute to its occurrence:
While SUDEP can happen to anyone with epilepsy, some people are at higher risk than others. The most common risk factor for SUDEP is having more than three generalized tonic-clonic seizures per year (DeGiorgio et al., 2017).
Preventing Sudden Unexpected Death in Epilepsy (SUDEP) entirely is challenging due to its complex and multifactorial nature. However, there are steps that individuals with epilepsy can take to reduce their risk of experiencing SUDEP:
While it may not be possible to prevent SUDEP entirely, implementing these preventive measures can help reduce the likelihood of experiencing SUDEP and improve overall outcomes for individuals living with epilepsy. It’s crucial for individuals with epilepsy and their caregivers to be proactive in managing the condition and advocating for their healthcare needs to minimize the risk of SUDEP.
SUDEP (Sudden Unexpected Death in Epilepsy) and sleep are closely intertwined, as SUDEP often occurs during sleep or in the immediate aftermath of sleep. Several factors related to sleep may influence the risk of SUDEP:
Overall, the relationship between SUDEP and sleep highlights the importance of comprehensive epilepsy care, which includes addressing sleep-related issues, optimizing seizure management, and promoting adherence to treatment regimens. Individuals with epilepsy and their healthcare providers should collaborate to identify and address factors that may increase the risk of SUDEP, with a particular emphasis on optimizing sleep quality and safety.
It’s important to talk to your doctor about Sudden Unexpected Death in Epilepsy (SUDEP), especially if you or a loved one have epilepsy. Your doctor can provide valuable information and guidance about SUDEP, including risk factors, preventive measures, and ways to optimize seizure management.
Discussing SUDEP with your doctor allows you to:
Overall, discussing SUDEP with your doctor is an essential aspect of comprehensive epilepsy care. Open communication with your healthcare team can help you reduce your risk of SUDEP and improve your overall quality of life while living with epilepsy. Ensuring that epilepsy is well-controlled with a combination of medication, diet, and/or other therapeutic mechanisms is essential to decreasing the risk of SUDEP. If you have epilepsy, ask your doctor to discuss the risk of SUDEP with you. To find an epilepsy specialist near you, click here.
It is estimated that over 3,000 people will die each year from SUDEP and it can happen to anyone with epilepsy, although certain individuals are at a greater risk. While certain steps can be taken to reduce this risk, there is a critical need for continued SUDEP research to understand the underlying biological mechanisms in order to prevent SUDEP.
Two recent epidemiological studies have helped to shed more light on the rates of SUDEP. A 2017 American Academy of Neurology/American Epilepsy Society report that involved an extensive literature review found SUDEP to affect 1/4500 children with epilepsy and 1/1000 adults with epilepsy each year. In contrast, in an examination of SUDEP rates in a cohort of individuals with epilepsy gleaned from the Swedish National Death Registry, Sveinsson et al. found the rate of SUDEP to be 1.11/1000 children less than 16 years of age per year, 1.13/1000 in individuals aged 16-50 per year and 1.29/1000 in individuals over 50 each year. The most important thing to remember is that while the incidence of SUDEP can differ depending upon the population studied, it is greatest in individuals with poorly-controlled seizures.
It is not clear why SUDEP happens. Because SUDEP is thought to occur either during or following a seizure, it is possible that it is due to a problem with the person’s heart, or breathing during or following the seizure.
The greatest risk factor for SUDEP is having tonic-clonic seizures (also known as grand mal). There is also a higher risk for people who have night-time seizures. Missing medications or not taking seizure medicines as prescribed may also put people at higher risk for SUDEP, because it can lead to more seizures.
As with adults, the answer generally depends upon how severe the epilepsy is. Some studies have found that risks for SUDEP in children are lower than in adults (Leestma et al., 1997; Harden et al., 2017); however, recent evidence suggests that SUDEP may be as prevalent in children as it is in adults, with about 1.11 cases of SUDEP per 1000 children with epilepsy (Sveinsson et al., 2017; Keller et al., Neurology 2018).
There are some studies that suggest genetic factors play a role, with certain genes implicated in some SUDEP cases (Bagnall et al., 2017). Research investigating the genetic link to SUDEP is still ongoing
There is no concrete data to support using these pillows. A recent study found that although so-called “anti-suffocation” pillows may reduce the amount of inspired CO2 compared to conventional pillows (which would seemingly reduce the risk of asphyxia), the total amount of CO2 accumulated with “anti-suffocation” pillows may still reach life-threatening amounts (Catcheside et al., 2014). You may wish to discuss any possible benefits with your doctor.
There are many types of devices out there that can alert seizures, alert changes in heart rate, or alert changes in breathing. Currently, no devices exist that can prevent SUDEP, however, there is some evidence that using a nighttime audio monitoring device may help inform of a major seizure event (Arends et al., 2016). However, research into the development of this technology is still ongoing.
The person must have a diagnosis of epilepsy for SUDEP to be considered. However, in SUDEP, the death may not be the direct result of a seizure. Although it is clear that a history of uncontrolled seizures increases the risk of SUDEP (DeGiorgio et al., 2017), the absence of evidence of a seizure prior to death does not preclude it from being deemed SUDEP.
Yes, in some cases. The North American SUDEP Registry (NASR), an international group of collaborating researchers, collects DNA and brain tissue to advance understanding of SUDEP. The purpose of the Registry is to provide researchers with a body of data that will result in greater understanding of SUDEP, its causes, and possible ways to reduce patient risk. Please call NASR at 855-432-8555 or visit the NASR website for more information on how to participate in this critical study.
You may also contact Dr. Alica Goldman, a neurologist specializing in the field of epilepsy. She and her colleagues at The Department of Neurology at Baylor College of Medicine are conducting a research study called “Ion Channels in Epilepsy*”. The aim of the research is the identification of the genetic risk factors that predispose an individual to epilepsy and to sudden death. This study is funded by The National Institutes of Health (NIH)/The National Institute for Neurological Disorders and Stroke (NINDS). In order to perform this research, the investigators need a blood sample or a small piece of fresh tissue from the person who died as a result of the seizure disorder. If you would like to learn more about this study or for participation, please contact Dr. Alica Goldman at (email: agoldman@bcm.edu) or the study coordinator, Eric Raap at (email: raap@bcm.edu; or phone: 713-798-2227). *This epilepsy study listing is for information purposes only; and the reader assumes full responsibility and risk for the appropriate use of the information provided. The information concerning the study was sent to the Epilepsy Foundation by the investigator or staff conducting the research. The Epilepsy Foundation, its affiliates, officers, directors, employees, and agents do not warrant or guarantee the accuracy or completeness of this information and specifically disclaims any liability therefore.